(MedPage Today) — A phase IIb trial in England suggested that a stimulation device cleared by the FDA in 2019 for children with attention-deficit/hyperactivity disorder (ADHD) may not be effective.
In 150 children and adolescents, those treated…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
